- D47.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D47.3 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D47.3 – other international versions of ICD-10 D47.3 may differ.
ICD-10-CM D47.3 is grouped within Diagnostic Related Group(s):
- 814 Reticuloendothelial and immunity disorders with mcc
- 815 Reticuloendothelial and immunity disorders with cc
- 816 Reticuloendothelial and immunity disorders without cc/mcc
Applicable To
- Essential thrombocytosis
- Idiopathic hemorrhagic thrombocythemia
- Primary thrombocytosis
Type 2 Excludes
- reactive thrombocytosis (D75.838)
- secondary thrombocytosis (D75.838)
- thrombocythemia NOS (D75.839)
- thrombocytosis NOS (D75.839)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D47.3:
- essential > Thrombocythemia (hemorrhagic) D75.839
- idiopathic > Thrombocythemia (hemorrhagic) D75.839
- primary > Thrombocythemia (hemorrhagic) D75.839
- essential > Thrombocytosis D75.839
- idiopathic > Thrombocytosis D75.839
- primary > Thrombocytosis D75.839